Resource
Low-Grade CRS and ICANS With Rondecabtagene Autoleucel, a Dual-Targeting CD19/CD20 CAR T-Cell Product Candidate, in Patients With Large B-Cell Lymphoma: Updated Safety Analysis
Publication Date: June 11, 2026
Source: The European Hematology Association (EHA)
Author(s): Sarah M. Larson, Tahir Latiff, Umar Farooq, Locke Bryan, Stefan Ciurea, Nebu Koshy, Boyu Hu, Bradley D. Hunter, Felix Mensah, Mehdi Hamadani, Hassaan Yasin, William Clark, Shashank Cingam, Matthew Fero, Sami Brake, YeonheeKim, David Shook, Akil Merchant
Resource Type: Poster